List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 96 studies with search of: "thrombotic thrombocytopenic purpura" OR "Purpura, Thrombocytopenic"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting ADAMTS13 in Thrombotic Thrombocytopenic Purpura
Condition: Thrombotic Thrombocytopenic Purpura
Intervention:
2 Recruiting Use of Rituximab Treatment in Addition to Standard Care for Newly Presenting Thrombotic Thrombocytopenic Purpura
Condition: Thrombotic Thrombocytopenic Purpura
Intervention: Drug: Rituximab
3 Recruiting Safety Study of Danazol With Plasma Exchange and Steroids for the Treatment of Thrombotic Thrombocytopenic Purpura
Condition: Thrombotic Thrombocytopenic Purpura
Intervention: Drug: Danazol
4 Not yet recruiting Rituximab in Adult Acquired Idiopathic Thrombotic Thrombocytopenic Purpura
Condition: Thrombotic Thrombocytopenic Purpura
Intervention: Drug: rituximab
5 Recruiting Study of Cyclosporine or Corticosteroids as an Adjunct to Plasma Exchange in Thrombotic Thrombocytopenic Purpura (TTP)
Condition: Thrombotic Thrombocytopenic Purpura
Interventions: Drug: Cyclosporine;   Drug: Prednisone
6 Terminated Safety and Efficacy Study To Compare Uniplas With Cryosupernatant Plasma In Thrombotic Thrombocytopenic Purpura (TTP)
Condition: Thrombotic Thrombocytopenic Purpura (TTP)
Intervention: Drug: Uniplas
7 Active, not recruiting The Use of Rituximab in Acute Thrombotic Thrombocytopenic Purpura (TTP)
Condition: Thrombotic Thrombocytopenic Purpura (TTP)
Intervention: Drug: Rituximab
8 Not yet recruiting Rituximab in Patients With Relapsed or Refractory TTP-HUS
Conditions: Thrombotic Thrombocytopenic Purpura;   Hemolytic Uremic Syndrome
Intervention: Drug: Rituximab
9 Suspended Evaluating the Effectiveness of Adding Rituximab to Standard Treatment for Thrombotic Thrombocytopenic Purpura (TTP) (The STAR Study)
Condition: Thrombotic Thrombocytopenic Purpura
Interventions: Drug: Rituximab;   Procedure: Plasma exchange;   Drug: Corticosteroids
10 Completed AMG 531 Versus Medical Standard of Care for Immune (Idiopathic) Thrombocytopenic Purpura
Conditions: Thrombocytopenic Purpura;   Idiopathic Thrombocytopenic Purpura;   Thrombocytopenia;   Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
Interventions: Biological: AMG531;   Drug: Medical Standard of Care for ITP
11 Recruiting Study of Veltuzumab (hA20) at Different Doses in Patients With ITP
Conditions: Purpura, Thrombocytopenic, Idiopathic;   Autoimmune Thrombocytopenic Purpura;   Purpura, Thrombocytopenic, Autoimmune
Intervention: Biological: veltuzumab
12 Active, not recruiting Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP)
Conditions: Chronic Idiopathic Thrombocytopenic Purpura;   Purpura, Thrombocytopenic, Idiopathic
Interventions: Drug: Placebo;   Drug: AKR-501 Tablets
13 Completed Retrospective & Prospective Observational Study of Subjects With ITP
Conditions: Idiopathic Thrombocytopenic Purpura;   Thrombocytopenia;   Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP);   Thrombocytopenic Purpura
Interventions: Other: Retrospective Chart Review;   Other: Patient-reported Outcome Questionnaires;   Other: Physician Survey
14 Recruiting International Registry and Biorepository for TMA(Thrombotic Microangiopathy)
Conditions: Thrombotic Microangiopathy;   Hemolytic Uremic Syndrome;   Thrombotic Thrombocytopenic Purpura
Intervention:
15 Completed An Epidemiological Study of Subjects With Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts, Endogenous Thrombopoietin Levels, Endogenous Anti-Thrombopoietin Antibodies, and Selected Autoimmune Markers
Conditions: Purpura, Thrombocytopenic, Idiopathic;   Immune Thrombocytopenic Purpura
Intervention:
16 Active, not recruiting Safety and Efficacy Study of AMG 531 to Treat ITP in Pediatric Subjects
Conditions: Idiopathic Thrombocytopenic Purpura;   Thrombocytopenia in Pediatric Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP);   Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
Interventions: Drug: AMG 531;   Drug: Placebo
17 Recruiting An Open Label Study of Romiplostim in Adult Thrombocytopenic Subjects With ITP
Conditions: Idiopathic Thrombocytopenic Purpura;   Thrombocytopenia;   Thrombocytopenic Purpura
Intervention: Biological: Romiplostim
18 Active, not recruiting Clinical Outcome Study of ARC1779 Injection in Patients With Thrombotic Microangiopathy
Conditions: Thrombotic Microangiopathy;   Thrombotic Thrombocytopenic Purpura
Interventions: Drug: ARC 1779 Placebo;   Drug: ARC1779 Injection
19 Active, not recruiting Pilot Study of R935788 for the Treatment of Adult Refractory Immune Thrombocytopenic Purpura (ITP)
Condition: Purpura, Thrombocytopenic, Idiopathic
Intervention: Drug: R935788
20 Recruiting Pilot Study of Rituximab for the Treatment of Acute Immune Thrombocytopenic Purpura (ITP)
Condition: Purpura, Thrombocytopenic, Idiopathic
Interventions: Drug: Rituximab;   Drug: Placebo

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services